CZ2012578A3 - Biologically degradable nanofibers or microfibers - Google Patents

Biologically degradable nanofibers or microfibers

Info

Publication number
CZ2012578A3
CZ2012578A3 CZ2012-578A CZ2012578A CZ2012578A3 CZ 2012578 A3 CZ2012578 A3 CZ 2012578A3 CZ 2012578 A CZ2012578 A CZ 2012578A CZ 2012578 A3 CZ2012578 A3 CZ 2012578A3
Authority
CZ
Czechia
Prior art keywords
microfibers
nanofibers
derivatives
biologically degradable
biodegradable
Prior art date
Application number
CZ2012-578A
Other languages
Czech (cs)
Inventor
Róbert Hromádka
Viera Šandriková
František Toman
Miloš Beran
Original Assignee
C2P S.R.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C2P S.R.O. filed Critical C2P S.R.O.
Priority to CZ2012-578A priority Critical patent/CZ2012578A3/en
Publication of CZ2012578A3 publication Critical patent/CZ2012578A3/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Biodegradovatelná nanovlákna a mikrovlákna pro sublinguální, bukální, orální, transdermální, rektální a vaginální administraci glutathionu a aplikace v krytech ran a spálenin. Tato nanovlákna nebo mikrovlákna obsahují 1 až 99 % hmotn. glutathinu v kombinaci s jedním nebo více polymerů ve formě škrobu nebo jeho derivátů a/nebo polyvinylalkohol a/nebo želatinu a/nebo kyselinu hyaluronovou a/nebo chitosan nebo jeho deriváty. Biodegradovatelná nanovlákna nebo mikrovlákna mají zpravidla průměr 40 až 1500nm a mohou být doplněna látkami, podporujícími vstřebávání sliznicemi nebo kůží v množství 0,01 až 30 % hmotn.Biodegradable nanofibers and microfibers for sublingual, buccal, oral, transdermal, rectal and vaginal administration of glutathione and applications in wound and burn wounds. These nanofibers or microfibers contain 1 to 99 wt. glutathine in combination with one or more polymers in the form of starch or derivatives thereof and / or polyvinyl alcohol and / or gelatin and / or hyaluronic acid and / or chitosan or derivatives thereof. Biodegradable nanofibers or microfibers generally have a diameter of 40 to 1500 nm and can be supplemented with substances that promote absorption through mucous membranes or skin in an amount of 0.01 to 30% by weight.

CZ2012-578A 2012-08-28 2012-08-28 Biologically degradable nanofibers or microfibers CZ2012578A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CZ2012-578A CZ2012578A3 (en) 2012-08-28 2012-08-28 Biologically degradable nanofibers or microfibers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ2012-578A CZ2012578A3 (en) 2012-08-28 2012-08-28 Biologically degradable nanofibers or microfibers

Publications (1)

Publication Number Publication Date
CZ2012578A3 true CZ2012578A3 (en) 2014-03-12

Family

ID=50237873

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2012-578A CZ2012578A3 (en) 2012-08-28 2012-08-28 Biologically degradable nanofibers or microfibers

Country Status (1)

Country Link
CZ (1) CZ2012578A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307059B6 (en) * 2016-11-03 2017-12-20 Nano Medical s.r.o. A method of producing a nanofibrous layer and a textile composite comprising a nanofibrous layer formed in this manner

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307059B6 (en) * 2016-11-03 2017-12-20 Nano Medical s.r.o. A method of producing a nanofibrous layer and a textile composite comprising a nanofibrous layer formed in this manner

Similar Documents

Publication Publication Date Title
WO2013109931A3 (en) Oral product
DOP2011000285A (en) 2-ACETAMIDO-5-ARIL-1, 2, 4-SUBSTITUTED TRIAZOLONS AND ITS USE
UY33776A (en) 1-BENCILCICLOALQUILCARBOXÍLICOS ACIDS SUBSTITUTED AND ITS USE
WO2012034079A3 (en) Macrolide dosage forms
PE20150997A1 (en) THERAPEUTIC NANOPARTICLES THAT INCLUDE A THERAPEUTIC AGENT AND METHODS TO MAKE THEM AND USE THEM
WO2015026400A3 (en) Orthodontic bracket
DOP2010000282A (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE
CR20110609A (en) ANTIMICROBIAL COMPOSITION AND RELATED METHODS OF USE
JP2012530141A5 (en)
CL2011000709A1 (en) Polymeric material comprising a polymer and silver nanoparticles dispersed in the polymer where the weight ratio between the polyomeric material and the silver nanoparticles is in a range of> 10:90 to <50:50.
CR20120017A (en) AUTOMATIC BRAKE DESCENSOR
PE20150288A1 (en) POLYMER BASED DIALYSATE
EP2589692A4 (en) Nanofibre laminate sheet
MX337891B (en) Antimicrobial tissue paper and process to manufacture same.
MX2014015392A (en) Biodegradable and flushable multi-layered film.
CL2012002825A1 (en) Composition comprising sexual pheromone of insect included in cyclodextrins, cyclodextrins of non-inclusion and water soluble polymers.
NZ619857A (en) A fast dissolving pharmaceutical composition
PE20151066A1 (en) SOLID DISPERSION WITH ENHANCED SOLUBILITY INCLUDING A TETRAZOLE DERIVATIVE AS AN ACTIVE INGREDIENT
JP2011528382A5 (en)
CL2011002928A1 (en) Use of a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan, to improve or maintain the gastrointestinal health or function of a progeny of a maternal animal by administration to the maternal animal and the composition used.
IN2014KN00938A (en)
TR201903940T4 (en) Dressing with extended release active ingredient.
CZ2012578A3 (en) Biologically degradable nanofibers or microfibers
MX367400B (en) Thermoplastic article with thermal active agent.
JP2013147480A5 (en)